Oncotelic Therapeutics (OTLC) Other Accumulated Expenses (2010 - 2026)
Oncotelic Therapeutics (OTLC) posted Other Accumulated Expenses of $175,000 for Q2 2026, up 250.0% from $50,000 a year earlier.
Powered by 
Analysis
Oncotelic Therapeutics (OTLC) Other Accumulated Expenses (2010 - 2026) Analysis & Trends
Since Q4 2010, Oncotelic Therapeutics has reported Other Accumulated Expenses for 58 quarters.
- Annual Other Accumulated Expenses shows a five-year compound annual growth rate of -14.9% (FY2020 to FY2025).
- In prior years, Oncotelic Therapeutics' Other Accumulated Expenses was $50,000 in FY2024 (unchanged), $50,000 in FY2023 (-85.0%), $332,432 in FY2022 (-17.6%) and $403,423 in FY2021 (+3.0%).
- Quarterly Other Accumulated Expenses has run from a low of $50,000 in Q4 2023 to a high of $425,740 in Q3 2021 over five years.
- On a year-over-year basis, Other Accumulated Expenses increased in two of the last six quarters, with growth averaging 83.3%.
- The strongest year-over-year quarter for Other Accumulated Expenses in the past five years was Q2 2026, with growth of 250.0%; the weakest was Q4 2023, with a decline of 85.0%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.83 Bn | 1,078.42 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 610.61 Bn | 529.14 Bn | 17.26 Bn |
| 3 | AbbVie | 500.66 Bn | 473.77 Bn | 12.70 Bn |
| 4 | Merck | 354.64 Bn | 309.02 Bn | 12.21 Bn |
| 5 | Novartis Ag | 291.14 Bn | 255.13 Bn | 11.24 Bn |
| 6 | Astrazeneca | 254.18 Bn | 227.87 Bn | 12.86 Bn |
| 7 | Amgen | 229.46 Bn | 184.86 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 190.33 Bn | 164.53 Bn | 6.22 Bn |
| 9 | Pfizer | 167.92 Bn | 114.57 Bn | 10.94 Bn |
| 10 | Oncotelic Therapeutics | 8.28 Mn | 7.42 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 175,000.00 |
| Dec 31, 2025 | 175,000.00 |
| Sep 30, 2025 | 50,000.00 |
| Jun 30, 2025 | 50,000.00 |
| Mar 31, 2025 | 50,000.00 |
| Dec 31, 2024 | 50,000.00 |
| Sep 30, 2024 | 50,000.00 |
| Jun 30, 2024 | 50,000.00 |
| Mar 31, 2024 | 50,000.00 |
| Dec 31, 2023 | 50,000.00 |
| Dec 31, 2022 | 332,432.00 |
| Sep 30, 2022 | 349,462.00 |
| Jun 30, 2022 | 339,460.00 |
| Mar 31, 2022 | 358,074.00 |
| Dec 31, 2021 | 403,423.00 |
| Sep 30, 2021 | 425,740.00 |
| Jun 30, 2021 | 322,995.00 |
| Mar 31, 2021 | 365,323.00 |
| Dec 31, 2020 | 391,631.00 |
| Sep 30, 2020 | 385,002.00 |
API Access
Oncotelic Therapeutics Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=OTLC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "OTLC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=OTLC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();